Cargando…
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis
Myasthenia gravis is an autoimmune disease in which immunoglobulin G (IgG) autoantibodies are formed against the nicotinic acetylcholine receptor (AChR) or other components of the neuromuscular junction. Though effective treatments are currently available, many commonly used therapies have important...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965493/ https://www.ncbi.nlm.nih.gov/pubmed/31998320 http://dx.doi.org/10.3389/fimmu.2019.03052 |